Tempest Therapeutics TPST SEC Filings

NASDAQ TPST
$0.91 0.00 (-0.10%)
As of: Sep 10, 2026 · 10:32 AM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Tempest Therapeutics, Inc. (TPST) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index